Clinical Trial Update: Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial [Phase 3]

View source ↗

Summary

A multicenter Phase 3 interventional trial for early-stage lymphangioleiomyomatosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis

Snippet

Sponsor: University of Cincinnati | Conditions: LAM, Lymphangioleiomyomatosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING